Reps Schrier, Langworthy Introduce Bipartisan Bill to Lower Prescription Drug Costs by Expanding Access to Biosimilars
legislation is supported by a broad coalition of healthcare providers, patient advocates, employers, insurers, and biosimilar manufacturers, including